399 related articles for article (PubMed ID: 24369685)
21. Phosphomimetic substitution at Ser-33 of the chloroquine resistance transporter PfCRT reconstitutes drug responses in
Sanchez CP; Moliner Cubel S; Nyboer B; Jankowska-Döllken M; Schaeffer-Reiss C; Ayoub D; Planelles G; Lanzer M
J Biol Chem; 2019 Aug; 294(34):12766-12778. PubMed ID: 31285265
[TBL] [Abstract][Full Text] [Related]
22. Functional Comparison of 45 Naturally Occurring Isoforms of the Plasmodium falciparum Chloroquine Resistance Transporter (PfCRT).
Callaghan PS; Hassett MR; Roepe PD
Biochemistry; 2015 Aug; 54(32):5083-94. PubMed ID: 26208441
[TBL] [Abstract][Full Text] [Related]
23. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
Lakshmanan V; Bray PG; Verdier-Pinard D; Johnson DJ; Horrocks P; Muhle RA; Alakpa GE; Hughes RH; Ward SA; Krogstad DJ; Sidhu AB; Fidock DA
EMBO J; 2005 Jul; 24(13):2294-305. PubMed ID: 15944738
[TBL] [Abstract][Full Text] [Related]
24. Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.
Martin RE; Butterworth AS; Gardiner DL; Kirk K; McCarthy JS; Skinner-Adams TS
Antimicrob Agents Chemother; 2012 May; 56(5):2283-9. PubMed ID: 22354298
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.
Shafik SH; Richards SN; Corry B; Martin RE
PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548
[TBL] [Abstract][Full Text] [Related]
26. Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt.
Pelleau S; Moss EL; Dhingra SK; Volney B; Casteras J; Gabryszewski SJ; Volkman SK; Wirth DF; Legrand E; Fidock DA; Neafsey DE; Musset L
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11672-7. PubMed ID: 26261345
[TBL] [Abstract][Full Text] [Related]
27. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT.
Kim J; Tan YZ; Wicht KJ; Erramilli SK; Dhingra SK; Okombo J; Vendome J; Hagenah LM; Giacometti SI; Warren AL; Nosol K; Roepe PD; Potter CS; Carragher B; Kossiakoff AA; Quick M; Fidock DA; Mancia F
Nature; 2019 Dec; 576(7786):315-320. PubMed ID: 31776516
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms of Drug Resistance in
Wicht KJ; Mok S; Fidock DA
Annu Rev Microbiol; 2020 Sep; 74():431-454. PubMed ID: 32905757
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
[TBL] [Abstract][Full Text] [Related]
30. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine.
Sá JM; Twu O; Hayton K; Reyes S; Fay MP; Ringwald P; Wellems TE
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18883-9. PubMed ID: 19884511
[TBL] [Abstract][Full Text] [Related]
31. The natural function of the malaria parasite's chloroquine resistance transporter.
Shafik SH; Cobbold SA; Barkat K; Richards SN; Lancaster NS; Llinás M; Hogg SJ; Summers RL; McConville MJ; Martin RE
Nat Commun; 2020 Aug; 11(1):3922. PubMed ID: 32764664
[TBL] [Abstract][Full Text] [Related]
32. Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter.
Summers RL; Dave A; Dolstra TJ; Bellanca S; Marchetti RV; Nash MN; Richards SN; Goh V; Schenk RL; Stein WD; Kirk K; Sanchez CP; Lanzer M; Martin RE
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1759-67. PubMed ID: 24728833
[TBL] [Abstract][Full Text] [Related]
33. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective.
Cooper RA; Hartwig CL; Ferdig MT
Acta Trop; 2005 Jun; 94(3):170-80. PubMed ID: 15866507
[TBL] [Abstract][Full Text] [Related]
34. Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter.
Coppée R; Sabbagh A; Clain J
Sci Rep; 2020 Mar; 10(1):4842. PubMed ID: 32179795
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia.
Golassa L; Enweji N; Erko B; Aseffa A; Swedberg G
Malar J; 2014 Mar; 13():120. PubMed ID: 24674605
[TBL] [Abstract][Full Text] [Related]
36. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
van Schalkwyk DA; Egan TJ
Drug Resist Updat; 2006; 9(4-5):211-26. PubMed ID: 17064951
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Plasmodium vivax Chloroquine Resistance Transporter Mutant Isoforms.
Hassett MR; Riegel BE; Callaghan PS; Roepe PD
Biochemistry; 2017 Oct; 56(41):5615-5622. PubMed ID: 28898049
[TBL] [Abstract][Full Text] [Related]
38. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance.
Bray PG; Martin RE; Tilley L; Ward SA; Kirk K; Fidock DA
Mol Microbiol; 2005 Apr; 56(2):323-33. PubMed ID: 15813727
[TBL] [Abstract][Full Text] [Related]
39. Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.
Griffin CE; Hoke JM; Samarakoon U; Duan J; Mu J; Ferdig MT; Warhurst DC; Cooper RA
Antimicrob Agents Chemother; 2012 Oct; 56(10):5356-64. PubMed ID: 22869567
[TBL] [Abstract][Full Text] [Related]
40. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America.
Mehlotra RK; Fujioka H; Roepe PD; Janneh O; Ursos LM; Jacobs-Lorena V; McNamara DT; Bockarie MJ; Kazura JW; Kyle DE; Fidock DA; Zimmerman PA
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12689-94. PubMed ID: 11675500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
